Acquired hemophilia A: Diagnosis, aetiology, clinical spectrum and treatment options

Autoimmunity Reviews

Volumn 10, Issue 6, 2011, Pages 311-316

  Shetty, Shrimati ^a   Bhave, Manali ^b   Ghosh, Kanjaksha ^a  

^a KEM HOSPITAL   (India)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Acquired hemophilia A; Autoantibodies; Factor VIII; Immunosuppressive therapy; Inhibitors

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; AUTOANTIBODY; BLOOD CLOTTING FACTOR 8 ANTIBODY; BLOOD CLOTTING FACTOR 8 CONCENTRATE; CYCLOSPORIN A; DESMOPRESSIN; IMMUNOGLOBULIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RITUXIMAB;

AGING; AUTOIMMUNE DISEASE; BLEEDING DISORDER; DISEASE ASSOCIATION; HEMARTHROSIS; HEMOPHILIA A; HUMAN; IMMUNOADSORPTION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; PARTIAL THROMBOPLASTIN TIME; PREGNANCY; RARE DISEASE; REVIEW;

AUTOIMMUNE DISEASES; HEMOPHILIA A; HUMANS;

EID: 79953161850     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2010.11.005     Document Type: Review

References (74)

1. Collins P., Macartney N., Davies R., et al. A population based, unselected, consecutive cohort of patients with acquired hemophilia A. Br J Haematol 2004, 124:86-90.
2. Collins P., Hirsch S., Baglin T.P., et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood 2007, 109:1870-1877.
3. Hay C.R., Brown S., Collins P.W., Keeling D.M., Liesner R. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors' Organisation. Br J Haematol 2006, 133:591-605.
4. Yee T.T., Taher A., Pasi K.J., Lee C.A. A survey of patients with acquired hemophilia in a hemophilia centre over a 28-year period. Clin Lab Haematol 2000, 22:275-278.
5. Green D., Lechner K. A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost 1981, 45:200-203.
6. Scandella D., Gilbert G.E., Shima M., et al. Some factor VIII inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248 through 2312, which overlap a phospholipid-binding site. Blood 1995, 86:1811-1819.
7. Franchini M., Targher G., Montagnana M., Lippi G. Laboratory, clinical and therapeutic aspects of acquired hemophilia A. Clin Chim Acta 2008, 395:14-18.
8. Franchini M., Gandini G., Di Paolantonio T., Mariani G. Acquired hemophilia A: a concise review. Am J Hematol 2005, 80:55-63.
9. Solymoss S. Postpartum acquired factor VIII inhibitors: results of a survey. Am J Hematol 1998, 59:1-4.
10. Franchini M. Postpartum acquired factor VIII inhibitors. Am J Hematol 2006, 81:768-773.
11. Trotta F., Bajocchi G., La Corte R., Moratelli S., Sun L.Y. Long-lasting remission and successful treatment of acquired factor VIII inhibitors using cyclophosphamide in a patient with systemic lupus erythematosus. Rheumatol Oxf 1999, 38:1007-1009.
12. Soriano R.M., Matthews J.M., Guerado-Parra E. Acquired hemophilia and rheumatoid arthritis. Br J Rheumatol 1987, 26:381-383.
13. Meiklejohn D.J., Watson H.G. Acquired hemophilia in association with organ-specific autoimmune disease. Haemophilia 2001, 7:523-525.
14. Hauser I., Lechner K. Solid tumors and factor VIII antibodies. Thromb Haemost 1999, 82:1005-1007.
15. Sallah S., Wan J.Y. Inhibitors against factor VIII in patients with cancer. Analysis of 41 patients. Cancer 2001, 91:1067-1074.
16. Franchini M., Targher G., Manzato F., Lippi G. Acquired factor VIII inhibitors in oncohematology: a systematic review. Crit Rev Oncol Hematol 2008, 66:194-199.
17. Sallah S., Nguyen N.P., Abdallah J.M., Hanrahan L.R. Acquired hemophilia in patients with hematologic malignancies. Arch Pathol Lab Med 2000, 124:730-734.
18. Dentale N., Fulgaro C., Guerra L., et al. Acquisition of factor VIII inhibitor after acute hepatitis C virus infection. Blood 1997, 90:3233-3234.
19. Sallah S., Wan J.Y. Inhibitors against factor VIII associated with the use of interferon-alpha and fludarabine. Thromb Haemost 2001, 86:1119-1121.
20. Moulis G., Pugnet G., Bagheri H., et al. Acquired factor VIII hemophilia following influenza vaccination. Eur J Clin Pharmacol 2010, 66:1069-1070.
21. Hauser I., Lechner K. Solid tumors and factor VIII antibodies. Thromb Haemost 1999, 82:1005-1007.
22. Green D., Lechner K. A survey of 215 non-hemophilic patients with inhibitors to Factor VIII. Thromb Haemost 1981, 45:200-203.
23. Yee T.T., Taher A., Pasi K.J., Lee C.A. A survey of patients with acquired hemophilia in a hemophilia centre over a 28-year period. Clin Lab Haematol 2000, 22:275-278.
24. Söhngen D., Specker C., Bach D., et al. Acquired factor VIII inhibitors in nonhemophilic patients. Ann Hematol 1997, 74:89-93.
25. Huang Y.W., Saidi P., Philipp C. Acquired factor VIII inhibitors in non-hemophilic patients: clinical experience of 15 cases. Haemophilia 2004, 10:713-721.
26. Angchaisuksiri P., Atichartakarn V., Pathepchotiwong K., et al. Experience with factor VIII: C inhibitors and acquired von Willebrand's disease in an adult at Ramathibodi Hospital. Southeast Asian J Trop Med Public Health 1993, 24:152-158.
27. Nagano T., Tani M., Hiramatsu Y., et al. A case of epidermolysis bullosa acquisita with bleeding tendency due to factor VIII inhibitor (acquired haemophilia). Br J Dermatol 2004, 151:716-717.
28. El-Osta H., Reddy P., Deutsch J.M. Acquired factor VIII inhibitors: case reports of paclitaxel and penicillin-induced entities. Blood Coagul Fibrinol 2009, 20:719-721.
29. Paul S., Javed U., Tevendale R., Lanford J., Liu R. Acquired factor VIII inhibitor in an HIV-infected patient after treatment with pegylated interferon-alpha 2a and ribavirin. AIDS 2007, 21:784-785.
30. Franchini M., Capra F., Nicolini N., et al. Drug-induced anti-factor VIII antibodies: a systematic review. Med Sci Monit 2007, 13:RA55-RA61.
31. Herman C., Boggio L., Green D. Factor VIII inhibitor associated with peginterferon. Haemophilia 2005, 11:408-410.
32. Seidler C.W., Mills L.E., Flowers M.E., Sullivan K.M. Spontaneous factor VIII inhibitor occurring in association with chronic graft-versus-host disease. Am J Hematol 1994, 45:240-243.
33. Broxson E.H., Hathaway W.E. Transplacental transfer of acquired factor VIII: C inhibitor. Thromb Haemost 1987, 57:126.
34. Hauser I., Schneider B., Lechner K. Post-partum factor VIII inhibitors. A review of the literature with special reference to the value of steroid and immunosuppressive treatment. Thromb Haemost 1995, 73:1-5.
35. Oldenburg J., Zeitler H., Pavlova A. Genetic markers in acquired hemophilia. Haemophilia 2010, 16:41-45.
36. Pavlova A., Zeitler H., Scharrer I., Brackmann H.H., Oldenburg J. HLA genotype in patients with acquired haemophilia A. Haemophilia 2010, 16:107-112.
37. Huth-Kühne A., Baudo F., Collins P., et al. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica 2009, 94:566-575.
38. Shetty S., Ghosh K., Mohanty D. An ELISA assay for the detection of factor VIII antibodies-comparison with the conventional Bethesda assay in a large cohort of haemophilia samples. Acta Haematol 2003, 109:18-22.
39. Kasper C.K. Laboratory tests for factor VIII inhibitors, their variation, significance and interpretation. Blood Coagul Fibrinol 1991, 2:7-10.
40. Verbruggen B., Novakova I., Wessels H., et al. The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability. Thromb Haemost 1995, 73:247-251.
41. Gawryl M.S., Hoyer L.W. Inactivation of factor VIII coagulant activity by two different types of human antibodies. Blood 1982, 60:1103-1109.
42. Spiezia L., Meneghetti L., Dalla Valle F., Tognin G., Radu C., Saggiorato G., et al. Potential role of thrombelastography in the monitoring of acquired factor VIII inhibitor hemophilia A: report on a 78-year-old woman with life-threatening bleedings. Clin Appl Thromb Hemost 2009, 15:470-476.
43. Delgado J., Jimenez-Yuste V., Hernandez-Navarro F., Villar A. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 2003, 121:21-35.
44. Baudo F., de Cataldo F. Blood disorders in the elderly. Acquired haemophilia in the elderly 2007, 389-407. Cambridge University Press, Cambridge. L. Balducci, W. Ershler, G. de Gaetano (Eds.).
45. Lottenberg R., Kentro T.B., Kitchens C.S. Acquired hemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy. Arch Intern Med 1987, 147:1077-1081.
46. Collins P., Baudo F., Huth-Kühne A., et al. Consensus recommendations for the diagnosis and treatment of acquired hemophilia A. BMC Res Notes 2010, 3:161.
47. Lak M., Sharifian R.A., Karimi K., Mansouritorghabeh H. Acquired hemophilia A: clinical features, surgery and treatment of 34 cases, and experience of using recombinant factor VIIa. Clin Appl Thromb Hemost 2010, 16:294-300.
48. Sallah S. Treatment of acquired hemophilia with factor eight inhibitor bypassing activity. Haemophilia 2004, 10:169-173.
49. Sahu S., Raipancholia R., Pardiwalla F.K., Pathare A.V. Hemostasis in acquired hemophilia-role of intracavitary instillation of EACA. J Postgrad Med 1996, 42:88-90.
50. Cattaneo M. Review of clinical experience of desmopressin in patients with congenital and acquired bleeding disorders. Eur J Anaesthesiol 1997, 14:10-14.
51. Lian E.C., Larcada A.F., Chiu A.Y. Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor. Ann Intern Med 1989, 110:774-778.
52. Sumner M.J., Geldziler B.D., Pedersen M., Seremetis S. Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal. Haemophilia 2007, 13:451-461.
53. Hay C.R., Negrier C., Ludlam C.A. The treatment of bleeding in acquired hemophilia with recombinant factor VIIa: a multicenter study. Thromb Haemost 1997, 78:1463-1467.
54. Aledort L.M. Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity. J Thromb Haemost 2004, 2:1700-1708.
55. Gandini G., Franchini M., Manzato F., Lippi G., Aprili G. A combination of prednisone, high-dose intravenous immunoglobulin and desmopressin in the treatment of acquired hemophilia A with high-titer inhibitor. Haematologica 1999, 84:1054.
56. Mudad R., Kane W.H. DDAVP in acquired hemophilia A: case report and review of the literature. Am J Hematol 1993, 43:295-299.
57. Morrison A.E., Ludlam C.A. Acquired hemophilia and its management. Br J Haematol 1995, 89:231-236.
58. Pintado T., Taswell H.F., Bowie E.J. Treatment of life-threatening hemorrhage due to acquired factor VIII inhibitor. Blood 1975, 46:535-541.
59. Kernoff P.B., Thomas N.D., Lilley P.A., et al. Clinical experience with polyelectrolyte-fractionated porcine factor VIII concentrate in the treatment of hemophiliacs with antibodies to factor VIII. Blood 1984, 63:31-41.
60. Morrison A.E., Ludlam C.A., Kessler C. Use of porcine factor VIII in the treatment of patients with acquired hemophilia. Blood 1993, 81:1513-1520.
61. O'Gorman P., Dimichele D.M., Kasper C.K., et al. Continuous infusion of porcine factor VIII in patients with haemophilia A and high-responding inhibitors: stability and clinical experience. Haemophilia 2001, 7:537-543.
62. Green D., Rademaker A.W., Briët E. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies. Thromb Haemost 1993, 70:753-757.
63. Sallah S., Aledort L. Treatment of patients with acquired inhibitors. J Thromb Haemost 2005, 3:595-597.
64. Schwartz R.S., Gabriel D.A., Aledort L.M., Green D., Kessler C.M. A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin. Blood 1995, 86:797-804.
65. Rivard G.E., St Louis J., Lacroix S., Champagne M., Rock G. Immunoadsorption for coagulation factor inhibitors: a retrospective critical appraisal of 10 consecutive cases from a single institution. Haemophilia 2003, 9:711-716.
66. Nemes L., Pitlik E. New protocol for immune tolerance induction in acquired hemophilia. Haematologica 2000, 85:64-68.
67. Zeitler H., Ulrich-Merzenich G., Hess L., et al. Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulating concept. Blood 2005, 105:2287-2293.
68. Stasi R., Brunetti M., Stipa E., Amadori S. Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia. Blood 2004, 103:4424-4428.
69. Wiestner A., Cho H.J., Asch A.S., et al. Rituximab in the treatment of acquired factor VIII inhibitors. Blood 2002, 100:3426-3428.
70. Onitilo A.A., Skorupa A., Lal A., et al. Rituximab in the treatment of acquired factor VIII inhibitors. Thromb Haemost 2006, 96:84-87.
71. Franchini M. Rituximab in the treatment of adult acquired hemophilia A: a systematic review. Crit Rev Oncol Hematol 2007, 63:47-52.
72. Aggarwal A., Grewal R., Green R.J., et al. Rituximab for autoimmune haemophilia: a proposed treatment algorithm. Haemophilia 2005, 11:13-19.
73. Au W.Y., Lam C.C., Kwong Y.L. Successful treatment of acquired factor VIII inhibitor with cyclosporin. Haemophilia 2004, 10:98-100.
74. Pardos-Gea J., Ordi-Ros J., Altisent C., et al. Acquired hemophilia A: successful treatment with immunosuppression, methylprednisolone pulses and oral cyclosporin. Thromb Haemost 2006, 95:735-737.